🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the safety, tolerability, pharmaco...
Status
Completed
Location
Clinical Trial Site
Start Date
2016-03-08
Trial ID
NCT02706886
The purpose of this study is to describe the natural history and progressio...
Status
Active Not Recruiting
Location
Clinical Trial Site
Start Date
2021-12-13
Trial ID
NCT04982393
Primary hyperoxaluria type 1 (PH1) is a rare genetic disease caused by muta...
Status
Recruiting
Location
CHU de Besançon
Start Date
2023-01-01
Trial ID
NCT06225882
Treatments Being Tested
The purpose of this study is to evaluate the efficacy, safety, pharmacokine...
Status
Completed
Location
Clinical Trial Site
Start Date
2020-01-21
Trial ID
NCT04152200
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of lumasir...
Status
Completed
Location
Clinical Trial Site
Start Date
2018-11-27
Trial ID
NCT03681184
The purpose of this study is to evaluate the efficacy, safety, pharmacokine...
Status
Completed
Location
Clinical Trial Site
Start Date
2019-04-22
Trial ID
NCT03905694
Treatments Being Tested
The purpose of this study is to provide expanded access to lumasiran for ad...
Status
Approved For Marketing
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT04125472
Treatments Being Tested
The purpose of this study is to evaluate the long-term safety and tolerabil...
Status
Completed
Location
Clinical Trial Site
Start Date
2018-04-04
Trial ID
NCT03350451
Treatments Being Tested
The primary purpose of this study is to evaluate the effect of lumasiran on...
Status
Terminated
Location
Clinical Trial Site
Start Date
2022-01-27
Trial ID
NCT05161936
This study will look at how well a drug that reduced the amount of oxalate ...
Status
Recruiting
Location
Charite Universtiätsmedizin
Start Date
2024-04-14
Trial ID
NCT06225544
Treatments Being Tested